tm logo

Monitor this mark

View On USPTO

SUPERLUMINAL MEDICINES
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 03 Sep 2024

Last Applicant/ Owned by

Superluminal Medicines, Inc.

200 Berkeley Street, 18th Floor

Boston

MA

02116

Serial Number

98212701 filed on 06th Oct 2023

Registration Number

N/A

Correspondent Address

Gregory B. Coy

GREGORY B. COY TAFT STETTINIUS & HOLLISTER LLP

INDIANAPOLIS, IN 46204

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SUPERLUMINAL MEDICINES

Development of pharmaceutical preparations and medicines Pharmaceutical agents modulating high value protein targets such as G protein coupled receptors

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Development of pharmaceutical preparations and medicines

First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products

Pharmaceutical agents modulating high value protein targets such as G protein coupled receptors

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98212701

Mark Type

No Service Mark

Attorney Docket Number

No SULUM-00002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
03rd Sep 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09th Jul 2024PUBLISHED FOR OPPOSITION
09th Jul 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19th Jun 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04th Jun 2024EXAMINERS AMENDMENT E-MAILED
04th Jun 2024EXAMINER'S AMENDMENT ENTERED
04th Jun 2024EXAMINERS AMENDMENT -WRITTEN
04th Jun 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04th Jun 2024APPROVED FOR PUB - PRINCIPAL REGISTER
28th May 2024ASSIGNED TO EXAMINER